Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study

Abstract
No abstract available
Funding Information
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2017-I2M-1-005)
  • Peking University
  • National Key Research and Development Program of China (2017YFC1308702, 2019YFC1315700)

This publication has 29 references indexed in Scilit: